NEW YORK (GenomeWeb) – Cepheid reported after the close of the market on Thursday a 16 percent year-over-year increase in its fourth quarter revenues. 

The Sunnyvale, Calif.-based firm said that for the three months ended Dec. 31, 2014 it had revenues of $131.5 million, up from $113.3 million in Q4 2013. It beat the consensus Wall Street estimate of $125.3 million. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.